Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease

J AAPOS. 2015 Feb;19(1):72-4. doi: 10.1016/j.jaapos.2014.08.013.

Abstract

We present a case of a child with unilateral group E retinoblastoma (according to the International Classification of Retinoblastoma) who received superselective intra-arterial chemotherapy as primary therapy. Although the tumor showed signs of regression, the patient developed orbital metastases requiring surgical excision and chemotherapy. Eventually the affected eye progressed to total retinal detachment and required enucleation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Child, Preschool
  • Cyclophosphamide / administration & dosage
  • Etoposide / administration & dosage
  • Eye Enucleation
  • Humans
  • Infusions, Intra-Arterial
  • Magnetic Resonance Imaging
  • Male
  • Microscopy, Acoustic
  • Orbital Neoplasms / drug therapy*
  • Orbital Neoplasms / secondary
  • Orbital Neoplasms / surgery
  • Retinal Neoplasms / drug therapy*
  • Retinal Neoplasms / pathology
  • Retinal Neoplasms / surgery
  • Retinoblastoma / drug therapy*
  • Retinoblastoma / secondary
  • Retinoblastoma / surgery
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Etoposide
  • Cyclophosphamide
  • Carboplatin

Supplementary concepts

  • CEV regimen